Evidence map›Paper›PMID 38764539›Full record

ArticleSAGE open medicine2024

Prevalence of cervical intraepithelial lesions and associated factors among women attending a cervical cancer clinic in Western Uganda; results based on Pap smear cytology.

Frank Ssedyabane, Nixon Niyonzima, Josephine Nambi Najjuma, Abraham Birungi, Raymond Atwine, Deusdedit Tusubira, Thomas C Randall, Cesar M Castro, Hakho Lee, Joseph Ngonzi

Abstract read
In one paragraph

Article in SAGE open medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Frank SsedyabaneDepartment of Medical Laboratory Science, Faculty of Medicine, Mbarara University of Science of Science and Technology, Mbarara, Uganda.ORCID https://orcid.org/0000-0002-6836-5749
Nixon NiyonzimaUganda Cancer Institute, Kampala, Uganda.
Josephine Nambi NajjumaDepartment of Nursing, Mbarara University of Science of Science and Technology, Mbarara, Uganda.
Abraham BirungiDepartment of Pathology, Mbarara University of Science of Science and Technology, Mbarara Uganda.
Raymond AtwineDepartment of Pathology, Mbarara University of Science of Science and Technology, Mbarara Uganda.
Deusdedit TusubiraDepartment of Biochemistry, Mbarara University of Science of Science and Technology, Mbarara, Uganda.ORCID https://orcid.org/0000-0002-4698-424X
Thomas C RandallDepartment of Global Health and Social Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Cesar M CastroCenter for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Hakho LeeCenter for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Joseph NgonziDepartment of Obstetrics and Gynecology, Mbarara University of Science of Science and Technology, Mbarara, Uganda.

Funding

Composing CODAs to cervical cancer screening through an integrated CRISPR and fluorescent nucleic acid approachU01CA279858 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI Cesar M Castro, Hakho Lee · 2023 to 2026
$2.1M
NCI NIH HHS U01 CA279858
6 · The paper itself

Abstract

Introduction: There are high incidence and mortality rates of cervical cancer among females in East Africa. This is exacerbated by limited up-to-date data on premalignant lesions and associated factors in this setting. In this study, we determined the prevalence of cervical intraepithelial lesions and associated factors among women attending the Mbarara Regional Referral Hospital cervical cancer clinic in Southwestern Uganda. Methods: In this cross-sectional study, 364 participants were recruited from among women attending the Mbarara Regional Referral Hospital cervical cancer clinic from 1 April to 30 June 2023. On consent, the study nurse collected demographic data and Pap smears, which were microscopically examined and reported by a laboratory scientist and a pathologist following the Bethesda grading system (2014). Statistical analyses were done in STATA version 17, using proportions, Chi-square, bivariate, and multivariate logistic regression analysis to determine associated factors at ⩽0.05 significance level. Results: The mean age of participants was 41.9 years. A third of all study participants (37.6%, 132/351) were contraceptive users, mostly hormonal contraceptives (87.1%, 115/132). Almost 88% (307/351) had an unknown Human Papilloma Virus status. The prevalence of cervical intraepithelial lesions among our study participants was 6.6% (23/351), of which 73.9% (17/23) were low-grade squamous intraepithelial lesions. More than half (9/17, 52.9%) of low-grade squamous intraepithelial lesions were active hormonal contraceptive users. Use of hormonal contraceptives (OR: 3.032, Conclusion: The prevalence of cervical intraepithelial lesions was 6.6%, lower than global estimates. Use of hormonal and intrauterine device contraceptives, as well as family history of cervical cancer, were significantly associated with cervical intraepithelial lesions among our study population. Prospective studies are recommended to further understand associations between different types of intrauterine devices and hormonal contraceptives, and cervical lesions.

Indexed as

ASCUScervical cancerCervical intraepithelial neoplasiaHSILLSILrisk factorsUganda

Identifiers

PMID38764539
PMCPMC11100407

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.